Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 49Breast 13Genitourinary 12Myeloid 10Thoracic 9Plasma cell 9Classical hematology 9Gynecologic 8Head & Neck 5Tumor-Agnostic 4Other neoplasm 3Dermatologic 3Sarcoma 2Other hematologic neoplasm 2CNS 2Other solid neoplasm 1Other 1Lymphoid 1

Conditions

Sarcoma 2Venous Thromboembolism 1Thromboembolism 1Hematoma 1Bone Neoplasms 1

Interventions

Radiotherapy 221Cyclophosphamide 211Doxorubicin 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 81Irinotecan 79pembrolizumab 75Radiation 70Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Surgical Procedures, Operative 57Peripheral Blood Stem Cell Transplantation 57Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Aspirin × Sarcoma × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT01696760 2018-12-05

Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology

Ohio State University Comprehensive Cancer Center

Phase NA Completed
12 enrolled 6 charts
Sarcoma

Sarcoma, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡